ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts


Listed below are the future JPAG meetings and selected partner meetings.
For past meetings or info on invoices, venue, posters & CPD, see right.

Thursday 9th December 2021
Regulatory Hot Topics VI
VIRTUAL EVENT : 1pm-4:30pm (UK GMT)

This symposium will address issues and challenges associated with the implementation of new and emerging guidelines. It will provide an excellent opportunity for dialogue, discussion and debate with speakers - several of whom have been very actively involved in shaping the guidance - and the peer group in an open forum.

Delegates will be able to understand, interpret and translate into day-to-day practice the guidance on various key emerging topics.

An excellent opportunity to learn from expert speakers involved in the development of the guidances on these key topics.

Anthony Barker - AstraZeneca
Dr Joel Bercu - Gilead
Dr Alistair Gibb - MHRA & BP Commission member
Kevin Hughes - Colorcon
Dr Jasvinder Singh - MHRA
Prof Ricky Wildman - University of Nottingham


Thursday 3rd February 2022
Automation of sample preparation
Royal Society of Chemistry, London
In recent years, most of the innovation seen in the pharmaceutical analysis arena has been on the instrumentation used for measurement and the analysis and interpretation of the data generated. At the same time the molecules coming out of discovery chemistry (often with poor solubility and / or bioavailability), are requiring formulators to develop sample matrices that are becoming increasingly complicated - including but not limited to amorphous solid dispersions, holt-melt extrudates and extended-release formulations. Extraction from these types of samples can be extremely challenging in terms of efficiency, reproducibility, cost, and transferability.

This JPAG symposium will discuss some of the challenges in the topic of sample preparation and provide examples of potential solutions in the form of innovative instrumentation, automation, and the application of existing methodology to inform and educate the audience about advances in sample preparation.


Thursday 24th March 2022
Challenges in the Development of Drug Delivery Devices
Royal Society of Chemistry, London
Drug-Device combination products such as inhalers, nasal sprays and autoinjectors present a range of unique challenges for their successful development and analysis. Effective performance testing is critical for understanding the quality of these products, with critical quality attributes often limited by device performance as much as traditional chemical stability trends.

In this event our expert speakers will discuss the current trends in the analysis of these complex products. Topics will include test automation, current inhaled in-vitro bioequivalence techniques, and the latest regulatory perspectives from the MHRA.


Thursday 12th May 2022
Antibody Drug Conjugate: The new science
Royal Society of Chemistry, London
Antibody drug conjugates (ADCs) are an exciting and challenging new area of research and are becoming ever more popular across the industry with more than 100 ADCs reported in the clinic. The targeted nature of the molecules makes them extremely suitable for delivering toxic molecules to the biological target.
However the complexity of the molecules and the lack of regulatory experience increases the complexity in discovery and development across all disciplines.
This symposium brings together experts from across the industry to share their knowledge and learning for an engaging and exciting meeting.


Thursday 30th June 2022
Stability VI
Royal Society of Chemistry, London
Continuing our successful series of stability meetings, this event is essential for anyone concerned with the management and assessment of drug stability. We have a group of expert speakers from academia, the regulator and industry who will provide background information, case studies and innovative approaches to stability testing. Posters are invited from industry and academia on any stability topics to facilitate additional interaction between attendees and speakers. The afternoon session will be split into smaller workshops on "hot" stability topics to allow active dialogue between delegates which will be summarised and closed out by a panel discussion.



Academy of Pharmaceutical Sciences EVENTS:

VIRTUAL PHARMSCI 2021, 7th, 8th and 9th September 2021
For details of this event see:


See www.ukclinicalpharmacy.org for details

All JPAG-hosted meetings award 4 hours of CPD points.

INVOICES & RECEIPTS are available: Please see the e-mail you receive after registration.

LOOKING FOR YOUR EVENT TICKET? Please see the e-mail you receive after registration.




We always seek feedback from delegates attending JPAG events through an Evaluation form.

A recent analysis of the results has shown that more than 95% of attendees thought that JPAG meetings were well planned, relevant and met their main objectives, and would recommend JPAG meetings to colleagues


I did appreciate receiving the slides before, as then I could print them and make notes around them during the symposium. (Jul 2021)

Getting an industry perspective on this topic was most helpful. (Jul 2021)

I appreciate having access to relevant JPAG seminars from overseas; provision of lectures beforehand to allow reading beforehand. (Jun 2021)

I did like having the presentations available early, with the webinar portion being focused on Q&A. (May 2021)

Fantastic to hear from NHS speaker, provides real insight to patient/clinician considerations that we don't necessarily see in industry. (Mar 2021)

From attendee perspective, the course did not take up the whole day as no travel necessary and overall good value for money. (Mar 2021)

Hearing the information from the clinical setting side was very useful. (Mar 2021)

Well organized. This was an amazing session. Prior sharing of the presentation was a great add on! (Dec 2020)

Liked the format of watching presentations and then summary with questions - gave a more joined feel to meeting. Thought the meeting was going to be quite dry but turned out to be engaging. (Dec 2020)

While I really enjoy getting the opportunity to visit Burlington House for JPAG events, I thought this was excellent digital alternative. Thank you to all JPAG organizers for organizing and managing the meeting. Thanks also to the speakers for their excellent slides, pre-recorded presentations as well as their summaries and Q&A sessions during the event. (Oct 2020)

Thank you for providing the presentations in advance made this a very efficient way of bringing us up to date. (Oct 2020)

Given the current worldwide circumstances, the format of the meeting with the videos and materials available beforehand, followed by the 'live' summaries and Q&A worked well. (Oct 2020)

Well done to all the speakers and the organisers for being able to successfully hold highly informative conferences virtually! (July 2020)

The most useful aspect of the webinar was the variety in the presentations across industry and the regulators. Really good to review the presentations beforehand. (July 2020)

A great alternative to real conference. (May 2020)

Good value, well organised symposium. Always useful for focused topics. (Feb 2020)

A very good day. Enjoyed getting to speak to the presenters to discuss current challenges in industry. (December 2019)

A good, well planned and interesting meeting. (December 2019)

JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.


Delegates at a symposium held at the Royal Society of Chemistry

© Joint Pharmaceutical Analysis Group 2021
Website by Delta Consultancy Services